Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This phase II study is to Evaluate the Safety and Efficacy of Neoadjuvant Chemotherapy
Combined With CCRT Followed by Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With
Stage IIIC2-IVB Cervical Cancer.（ CRTCP）